InSphero AG
8952 Schlieren, Wagistrasse 27
+41 44 515049-0
info@insphero.com
InSphero is a leading supplier of organotypic, biological in vitro 3D microtissues for highly predictive drug testing. The company currently counts all of the top ten global pharmaceutical and cosmetics companies as customers and is helping them to implement its patented microtissue technology in their development work-flow.
InSphero AG
Wagistrasse 27
8952 Schlieren
6 Ergebnisse für "chemotherapeutics" unter InSphero AG
European Radiation Research Society (ERR) 2013 40th Annual Meeting,...
... based approach to identify chemotherapeutics that modify radiation-therapy response Top links ... identify chemotherapeutics that modify radiation-therapy response Top links Hanging-drop Technology ...
Folie 1
... chemotherapeutics in cellular response to combined radiation and drug treatment. The therapy target was the ... 10 classical chemotherapeutic compounds. These chemotherapeutics were tested alone and in combination ... chemotherapeutics in cellular response to combined radiation and drug treatment. The therapy target was the ... 10 classical chemotherapeutic compounds. These chemotherapeutics were tested alone and in combination ...
Swiss Bioscience GmbH
https://www.swissbioscience.com/
8952 Schlieren, Wagistrasse 27a
+41 (0) 44 731 99 00
info@swissbioscience.com
Swiss Bioscience GmbH manufactures and banks stem cells for individuals and provides pharmaceutical grade SVF* and hADSCs** produced under cGMP*** conditions. (* Stromal Vascular Fraction extracted from human lipoaspirate, ** Human Adipose Tissue Derived Stem Cells, *** Current Good Manufacturing Practice)
Swiss Bioscience GmbH
Wagistrasse 27a
8952 Schlieren
1 Ergebnisse für "chemotherapeutics" unter Swiss Bioscience GmbH
SBS | Patented Lipds Nanopartical
... ( chemotherapeutics and other drugs) to improve the quality of life and prognosis of cancer patients worldwide. ... of cancer drugs ( chemotherapeutics and other drugs) to improve the quality of life and prognosis of ...
Somagenetix
https://www.wysszurich.ch/projects/somagenetix
8952 Schlieren, Wagistrasse 23
Gene therapy solutions for patients with severe inherited diseases.
Somagenetix
Wagistrasse 23
8952 Schlieren
9 Ergebnisse für "chemotherapeutics" unter Somagenetix
UZH - Department of Chemistry - ERC Consolidator Grant
... may constitute the basis for a new generation of powerful and safe antitumor chemotherapeutics ... powerful and safe antitumor chemotherapeutics. Kerstin Möhle Research News More news 29.05.2020 Nina ...
Intercalation-enhanced “Click” Crosslinking of DNA - Zurich Open Re...
... Copy Abstract DNA–DNA cross‐linking agents constitute an important family of chemotherapeutics that ... . Abstract DNA–DNA cross‐linking agents constitute an important family of chemotherapeutics that non ... agents constitute an important family of chemotherapeutics that non‐specifically react with endogenous ... family of chemotherapeutics that non‐specifically react with endogenous nucleophiles and therefore ...
ETH Zürich - Numerische Materialmodellierung
8005 Zürich, Technoparkstrasse 1 / Einstein PFA G 11 (2. OG)
ETH Zürich - Numerische Materialmodellierung
Technoparkstrasse 1
8005 Zürich
5 Ergebnisse für "chemotherapeutics" unter ETH Zürich - Numerische Materialmodellierung
Detailed view of a molecular toxin transporter | ETH Zurich
... drugs ( chemotherapeutics). This is particularly serious because certain tumour cells are able to ... chemotherapeutics. “The contributions of our research to medicine, particularly cancer medicine, should really be ... drugs ( chemotherapeutics). This is particularly serious because certain tumour cells are able to ... chemotherapeutics. “The contributions of our research to medicine, particularly cancer medicine, should really be ...
Detailed view of a molecular toxin transporter | ETH Zurich
... drugs ( chemotherapeutics). This is particularly serious because certain tumour cells are able to ... chemotherapeutics. “The contributions of our research to medicine, particularly cancer medicine, should really be ... drugs ( chemotherapeutics). This is particularly serious because certain tumour cells are able to ... chemotherapeutics. “The contributions of our research to medicine, particularly cancer medicine, should really be ...
ETH Zürich - Feasibility Lab
Technoparkstrasse 1
8005 Zürich
1 Ergebnisse für "chemotherapeutics" unter ETH Zürich - Feasibility Lab
Platinum nanoparticles for selective treatment of liver cancer cell...
... ) and occurs in this form in conventional platinum-based chemotherapeutics. Non-oxidised platinum(0 ... ) and occurs in this form in conventional platinum-based chemotherapeutics. Non-oxidised platinum(0 ...
University Hospital Zurich, Research and Education Office
https://www.usz.ch/forschung/Seiten/default.aspx
8091 Zürich, Rämistrasse 100
The University Hospital Zurich is one of Switzerland’s largest hospitals and a pioneering institution in the field of clinical research. In its 40 departments and institutes, it assembles and practices all medical disciplines and enjoys an excellent reputation for state-of-the-art medicine, professional and com- passionate patient care, and groundbreaking bench-to-bedside translational medical research.
University Hospital Zurich, Research and Education Office
Rämistrasse 100
8091 Zürich
9 Ergebnisse für "chemotherapeutics" unter University Hospital Zurich, Research and Education Office
Eberli Gruppe – UniversitätsSpital Zürich
... exhibit enrichment of known tumor associated antigens, resistance to conventional chemotherapeutics, and ... conventional chemotherapeutics, and increased production of extracellular vesicles (EVs) – all hallmarks of ...
Eberli Gruppe – UniversitätsSpital Zürich
... exhibit enrichment of known tumor associated antigens, resistance to conventional chemotherapeutics, and ... conventional chemotherapeutics, and increased production of extracellular vesicles (EVs) – all hallmarks of ...
University of Zurich
https://www.campus-schlieren.uzh.ch/en.html
8952 Schlieren, Wagistrasse 12
The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.
University of Zurich
Wagistrasse 12
8952 Schlieren
1 Ergebnisse für "chemotherapeutics" unter University of Zurich
UZH Publikation A4
... with resistance to conventional chemotherapeutics but sensitivity to glucocorticoids, anthracyclines ... with resistance to conventional chemotherapeutics but sensitivity to glucocorticoids, anthracyclines ...
ANSYS Switzerland GmbH
8005 Zürich, Technoparkstrasse 1 / Zeppelin 3003
+41 44 500 93 60
ANSYS ist der weltweit führende Anbieter von technischen Simulationslösungen und entwickelt, vertreibt und unterstützt Software für Engineering Simulation. Was ANSYS auszeichnet und von anderen professionellen Berechnungsprogrammen abhebt, ist unter anderem seine Multiphysikfähigkeit. Es kann neben Mechanik und Heattransfer ebenso Fluidynamik, Akustik und Elektromagnetik berechnet werden. Auch die gleichzeitige gekoppelte Behandlung dieser physikalischen Aspekte in einer Simulation ist abgedeckt.
ANSYS Switzerland GmbH
Technoparkstrasse 1
8005 Zürich
1 Ergebnisse für "chemotherapeutics" unter ANSYS Switzerland GmbH
ANSYS Advantage - Special Issue: Oil and Gas 2015
... deliver chemotherapeutics to the bladder in a heat-activated manner. The simulated power deposition ... deliver chemotherapeutics to the bladder in a heat-activated manner. The simulated power deposition ...
